Drug Patents owned by Scilex Pharms Inc

1. List of Ztlido drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9925264 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

US9283174 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

US10765640 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

US9931403 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

US10765749 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

US11278623 SCILEX PHARMS INC Non-aqueous patch
May, 2031

(8 years from now)

Drugs and Companies using LIDOCAINE ingredient

Market Authorisation Date: 28 February, 2018

Treatment: Method for relieving the pain associated with post-herpetic neuralgia

Dosage: PATCH;TOPICAL

How can I launch a generic of ZTLIDO before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in